M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

28 deals · US$77bndisclosed · Diagnostics · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Oct 2026 Select assets of BioReference Health OPKO HealthLabcorpAsset saleAnnounced–Diagnostics+1 Lazard
Sep 2026 MLM Medical Labs –LabcorpAcquisitionAnnounced–Clinical Trial Services+1 William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side)
Aug 2026 Lantheus Holdings –Curium US HoldingsAcquisitionAnnounced8,000.0Radiopharmaceuticals+1 Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side)
Jul 2026 Personalis –Tempus AIAcquisitionAnnounced1,900.0Diagnostics+2 Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side)
Jul 2026 XpresSpa Holdings XWELLExpress Wellness GroupAcquisitionAnnounced13.0Consumer Services+2 Roth Capital Partners (sell-side)Haynes Boone (sell-side)Dechert (buy-side)
Jul 2026 Dreampath Diagnostics –HalmaAcquisitionAnnounced–Diagnostics+1 Latham & Watkins (sell-side)
Jul 2026 VitalRads ThriveZoetisAcquisitionAnnounced–Animal Health+1 Guggenheim Securities (sell-side)
Jun 2026 Bio-Techne –Merck KGaAAcquisitionPending11,300.0Life Sciences+1 Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side)
Jun 2026 Ignite Proteomics AditxtProposed Ignite Proteomics Inc. holding companyMergerPending150.0Life Sciences+2 Ladenburg Thalmann
Jun 2026 Vesica Health –Photocure ASAAcquisitionCompleted30.5Diagnostics DNB Carnegie (buy-side)Morgan Lewis (buy-side)Selmer (buy-side)
Jun 2026 SAGA Diagnostics –RocheAcquisitionAnnounced595.0Diagnostics+1 Davis Polk (buy-side)
May 2026 Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group –Tamarind HealthAcquisitionAnnounced–Healthcare Services+2 Goodwin (buy-side)
May 2026 PathAI –RocheAcquisitionPending750.0Healthcare Software+2 Latham & Watkins (sell-side)Davis Polk (buy-side)
Apr 2026 Naveris –CareDxAcquisitionAnnounced160.0Diagnostics+1 J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Goldman Sachs (buy-side)Fenwick & West (buy-side)
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleAnnounced1,075.0Diagnostics+1 Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side)
Mar 2026 Biocare Medical –Agilent TechnologiesAcquisitionAnnounced950.0Diagnostics+1 Sullivan & Cromwell (buy-side)
Feb 2026 Masimo –DanaherAcquisitionAnnounced9,900.0Medtech+1 McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side)
Feb 2026 LKC Technologies DW Healthcare PartnersAMETEKAcquisitionAnnounced–Medtech+2 William Blair (sell-side)
Jan 2026 Lantheus SPECT business LantheusSHINE TechnologiesAsset saleAnnounced–Pharma+2 Solomon Partners (sell-side)
2026 Stago –ARCHIMEDAcquisitionAnnounced–Diagnostics Moelis & Company (sell-side)
2026 MediGroup DECALIA CapitalImaOneAcquisitionAnnounced–Diagnostics+1 Lincoln International (sell-side)
2026 Sebia –Warburg PincusStakeAnnounced–Diagnostics Moelis & Company (buy-side)
Dec 2025 FONAR –Timothy R. DamadianAcquisitionAnnounced–Medtech+2 Marshall & Stevens (sell-side)DLA Piper (sell-side)
Dec 2025 Bako Diagnostics selected assets –Fulgent GeneticsAcquisitionCompleted56.9Diagnostics+1 Latham & Watkins (sell-side)Piper Sandler (buy-side)Mintz (buy-side)
Dec 2025 Freenome Holdings –Perceptive Capital Solutions CorpMergerCompleted725.0Diagnostics+2 TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)
Nov 2025 Exact Sciences –AbbottAcquisitionAnnounced23,000.0Diagnostics Centerview Partners (sell-side)XMS Capital Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Jul 2025 BD Biosciences & Diagnostic Solutions business Becton, Dickinson and CompanyWatersAsset saleCompleted18,800.0Life Sciences+2 Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side)

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.